Xencor reported 29.92 in PE Price to Earnings for its fiscal quarter ending in September of 2022.


Pe Change Date
AbbVie 18.41 69.26 Jun/2025
Amgen 12.51 28.7 Jun/2025
Arrowhead Research 436.79 383.28 Jun/2020
AstraZeneca 20.04 12.31 Jun/2025
Biogen 12.41 0.17 Jun/2025
Bristol-Myers Squibb 17.27 3.22 Jun/2025
GlaxoSmithKline GBP 18.27 5.23 Jun/2025
J&J 19.02 9.62 Jun/2025
Merck 8.58 4.74 Jun/2025
Novartis 15.89 3.03 Jun/2025
Pfizer 9.12 8.86 Jun/2025
Regeneron Pharmaceuticals 13.35 3.19 Jun/2025
Roche Holding 19.32 1.87 Jun/2024
Xencor 29.92 3.22 Sep/2022